Physician profile
Jordan Forcey
NPI 1689497786
$1,913.18
in general payments reported to CMS, 2019-2025
19 companies · $1,665 in 2025
The $1,665 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $248 · 2025: $1,665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610 · Education: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,610.25 |
| Education | $302.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $386.20 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Glaxosmithkline, LLC. | $307.29 | 2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $253.22 | 2025 | Tezspire, Airsupra, Breztri |
| Regeneron Healthcare Solutions, INC. | $142.79 | 2025 | Dupixent |
| Verona Pharma, INC. | $135.98 | 2025 | Ohtuvayre |
| Electromed, INC. | $104.87 | 2025 | Smartvest |
| Sanofi-Aventis U.S. LLC | $94.95 | 2025 | |
| Grifols USA, LLC | $83.14 | 2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.44 | 2024 | Ofev |
| Insmed, INC. | $64.79 | 2025 | Arikayce |
| Genzyme Corporation | $56.29 | 2025 | |
| Noah Medical Corporation | $54.06 | 2024 | Galaxy |
| Ambu INC. | $35.15 | 2025 | |
| Vifor Pharma, INC. | $26.23 | 2025 | Zemaira |
| Fisher & Paykel Healthcare INC | $25.69 | 2025 | Fisher & Paykel Healthcare |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $22.45 | 2025 | Glassia |
| Pfizer INC. | $19.61 | 2025 | |
| Amgen INC. | $16.09 | 2025 | Tezspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1.94 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Forcey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.